Patents
Patents for C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or (11,041)
07/2008
07/10/2008US20080167475 Intermediates of 2-substituted carbapenem derivatives and process for production thereof
07/10/2008CA2710046A1 N3-heteroaryl substituted triazoles and n5-heteroaryl substituted triazoles useful as axl inhibitors
07/10/2008CA2673965A1 Pyrazolopyrimidine compound
07/09/2008EP1940847A2 Pyrazolopyrimidines as protein kinase inhibitors
07/09/2008EP1940835A1 Pyrazolo[3,4-b]pyridine compounds, and their use as pde4 inhibitors
07/09/2008EP1940401A2 Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators
07/09/2008CN101214248A Triazolo[4,5-d] pyrimidine derivatives and their application as purinergic receptor antagonists
07/09/2008CN100400540C Isoxazoline derivatives as anti-depressants
07/09/2008CN100400042C Methods for making sustained release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof
07/08/2008US7396926 Compound for use in the measurement of gene expression
07/03/2008WO2008077811A1 Spiro-piperidine derivatives
07/03/2008US20080161572 Preparation Method
07/03/2008CA2674518A1 Spiro-piperidine derivatives
07/02/2008EP1939202A1 Novel adenine compound
07/02/2008EP1937691A1 Thieno-pyrimidine compounds having fungicidal activity
07/02/2008EP1474425B9 Deazapurines and uses thereof
07/02/2008CN100398545C Thienopyrazoles
07/01/2008US7393957 Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments
07/01/2008US7393859 Amide substituted imidazoquinolines
07/01/2008US7393551 Denatured carob flour (DCF) with a low content of soluble tannins and sugars, meant for human consumption and process to obtain it
06/2008
06/26/2008WO2008075109A1 Substituted piperidines having protein kinase inhibiting activity
06/26/2008WO2008047201A3 Solid dispersion comprising a poorly water soluble drug
06/26/2008US20080153899 Fatty amine drug conjugates
06/26/2008US20080153855 Chemical Compounds
06/25/2008EP1670796B1 Imidazopyridine-derivatives as inducible no-synthase inhibitors
06/25/2008EP1430147A4 Fluorescent quenching detection reagents and methods
06/19/2008WO2008072655A1 Imidazothiazole derivatives
06/19/2008WO2008072634A1 Fused heterocyclic compound
06/19/2008WO2008071964A1 Naphthyridine bactericides
06/19/2008WO2008071962A1 Pteridines and pyrimidinopyridines as antibacterial agents
06/19/2008WO2008071937A1 Novel fluorescent kinase ligands and assays employing the same
06/19/2008US20080146546 Bicyclic and Tricyclic Heteroaromatic Compounds
06/19/2008CA2673097A1 Fused heterocyclic compound
06/19/2008CA2672565A1 Imidazothiazole derivatives
06/18/2008EP1931674A2 Deazapurines useful as inhibitors of janus kinases
06/18/2008CN101203519A 2-amido-6-amino-8-oxopurine derivatives as ToII-like receptor modulators for the treatment of cancer and viral infections, such as hepatitis c
06/18/2008CN101203516A Purine and imidazopyridine derivatives for immunosuppression
06/18/2008CN101200457A Dihydro pteridinone, method for making the same and uses as pharmaceutical preparation thereof
06/12/2008WO2008068392A1 Novel imidazo[1,2-a]pyridine-3-ylamine fluorophore derivatives and process for the preparation thereof
06/12/2008WO2008068185A1 Spiro-piperidine derivatives as via receptor antagonists
06/12/2008WO2007081597A3 Peri condensed tricyclic compounds useful as antibacterial agents
06/12/2008US20080139812 Heterocyclical Chromophore Architectures
06/12/2008CA2671990A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
06/12/2008CA2670674A1 Spiro-piperidine derivatives as via receptor antagonists
06/11/2008EP1492803B1 New analogs of nitrobenzylthioinosine
06/11/2008EP1255739B1 3-aminoquinazolin-2,4-dione antibacterial agents
06/11/2008CN100393789C Composition stablized to heat, oxidation or optical degradation stablized mixture and its preparation process
06/10/2008US7384952 1-(3-ethoxybenzyl)-4-[4-[4-[2-(dimethylamino)ethoxy]benzoyl]piperazin-1-yl]-1H-pyrazolo[3,4-d]pyrimidine; small conductance potassium channel (SK channel) blocking activity; gastrointestinal disorders
06/10/2008US7384950 Respiratory system disorders; asthma; chronic obstructive pulmonary disease
06/10/2008US7384946 M3 muscarinic acetylcholine receptor antagonists
06/10/2008US7384931 Constrained compounds as CGRP-receptor antagonists
06/10/2008US7384930 [9-(2,2-Dimethyl-propyl)-8-oxo-3,6,7,8,9,10-hexahydro-2,3,9-triaza-(S)-cyclohepta[e]inden-7-yl]-acetic acid methyl ester; calcitonin gene-related peptide receptor antagonist; analgesic, antiinflammatory agent; migraine, neurogenic vasodilation, circulatory shock, menopause, asthma
06/10/2008US7384928 7-side chain is substituted with aminothiazole and 3-position with a cyclic-type quarternary ammoniummethyl group; antibacterial activities against cephem-resistant Pseudomonas aeruginosa which produce beta -lactamase; antibiotic resistance; pharmacokinetics; high water solubility; injection
06/05/2008US20080132526 Purine Derivative
06/05/2008DE60129697T2 Kondensierte azepinderivate und ihre verwendung als antidiuretisches mittel Condensed azepine derivatives and their use as antidiuretic agent
06/04/2008CN101193899A Monomers, oligomers and polymers of thieno (3, 4-D) thiazole
06/03/2008US7381723 Antiserotonine agents; stroke, brain disorders;trauma; Alzheimer's disease; neurodegenerative disease; schizophrenia; psychological disorders; anxiolytic agents; controlling stresses; eating disorders; sleep disorders; sexual disorders
06/03/2008US7381720 Tumor suppression agents with reduced side effects; anticancer; antibacterial and antiviral
06/03/2008CA2180829C Cephalosporin synthesis
05/2008
05/29/2008WO2008019356A3 Process for the preparation of substituted-1,2,3,4-tetrahydroisoquinoline derivates
05/29/2008CA2636242A1 Heterobicyclic thiophene compounds and methods of use
05/28/2008EP1925618A1 Imidazopyridine-based compounds and organic light emitting diode including organic layer comprising the imidazopyridine-based compounds
05/28/2008EP1925614A1 Anxiolytic agents with reduced sedative and ataxic effects
05/28/2008EP1660475B1 Pyrimidylpyrrole derivatives active as kinase inhibitors
05/28/2008EP1501507B1 Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activity
05/28/2008CN101189227A New derivatives of pyrrolyltriazine together with methods for obtaining them and their use as protecting agents against uv radiation
05/28/2008CN100390178C Polycycloalkylpurines as adenosine receptor antagonists
05/27/2008US7378534 Anti-first-pass effect compounds
05/27/2008US7378524 e.g., 6-chloro-2-methyl-4-(N-(2-(N-(p-methoxyphenylsulfonyl)-N-(2-(2,5-dimethoxy-4-nitroanilinocarbonyl)ethyl)amino)ethyl)amino)quinoline; used to treat inflammatory and immune diseases by binding to CXCR3 receptors.
05/27/2008US7378411 Substituted thienopyrimidinones as a mitotic kinesin inhibitor
05/22/2008WO2008060301A1 7-substituted purine derivatives for immunosuppression
05/22/2008CA2669886A1 Compounds useful as protein kinase inhibitors
05/22/2008CA2669686A1 7-substituted purine derivatives for immunosuppression
05/21/2008EP1456206B1 Azaindolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands
05/15/2008WO2008057054A1 Dna complexing agents
05/15/2008WO2008056187A1 Imidazolopyrimidines and imidazolotriazine derivatives as inhibitors of poly(adp-ribose) polymerase (parp)
05/15/2008US20080114023 Azaindolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands
05/15/2008US20080113972 Enzyme inhibitors of cGMP-metabolizing phosphodiesterases, for TREATMENT OF CARDIOVASCULAR DIORDERS, CEREBROVASCULAR DISORDERS, UROGENITAL DISORDERS AND ERECTILE DYSFUNCTION; chemical synthesis
05/15/2008US20080113971 improved potency; reduced undesirable side effects; pain, inflammation, arthritis etc; ethyl 1-(2-aminoethyl)-3-pyridin-4-yl-1H-pyrazole-5-carboxylate dihydrochloride
05/15/2008US20080113941 4-O esters of podophyllotoxin and 4'-demethylepipodophyllotoxin 4'-phosphonic acid or phosphonate derivatives; anticancer agents; type II DNA topoisomerase (topoisomerase II) inhibitors
05/15/2008US20080109989 Stacking wall panel system and methods of installation and use
05/15/2008CA2669432A1 Imidazolopyrimidines and imidazolotriazine derivatives as inhibitors of poly(adp-ribose) polymerase (parp)
05/14/2008EP1919475A1 Tetrahydro- beta-carbolin-sulfonamide derivatives as 5-ht6 ligands
05/13/2008US7371470 Pyran derivative
05/08/2008WO2008055013A2 5-oxo-5,8 - dihydro - pyrido - pyrimidines as inhibitors of c-fms kinase
05/08/2008WO2008052441A1 Inhibitors for disrupting the interaction of ubiquitination related enzymes and uses thereof
05/08/2008US20080108644 alkaloids; anticarcinogenic, antiproliferative agent; inhibitor of cellular mitosis and cell proliferation; binding to tubulin leads to cell cycle arrest in M phase and subsequently to apoptosis; antiallergen, antiinflammatory, antidiabetic, autoimmune diseases; asthma, arthritis, Alzheimer' disease
05/08/2008US20080108605 Anxiolytic agents with reduced sedative and ataxic effects
05/08/2008US20080108141 2,3-diaminonaphthalene reacts with nitric oxide to give fluorescent naphthalenetriazole
05/07/2008EP1383774B1 Dihydroimidazo¬4,5-e indole and 7h-pyrrolo¬3,2-f quinoxaline derivatives as nicotinic acetylcholine receptor ligands and/or serotonergic ligands
05/07/2008CN101172981A 2,3-dihydroimidazo[2,1-b]oxazole compound
05/07/2008CN100386329C Substituted 3-amino-thieno(2,3-b)pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses
05/06/2008US7368459 Heterocyclic compounds
05/06/2008US7368438 Non-nucleotide compositions and method for inhibiting platelet aggregation
05/06/2008US7368437 Bicyclic heterocycles, processes for their preparation and their use as herbicides and pharmaceutical agents
05/06/2008CA2327468C Semi-synthetic ecteinascidins
05/02/2008WO2008051552A2 Organic semiconductor materials and methods of preparing and use thereof
05/02/2008WO2008050871A1 Crystalline carbapenem compounds
05/02/2008WO2008049994A1 New fluorene derivatives, compositions containing the same and use thereof as inhibitors of the protein chaperone hsp 90
05/02/2008CA2667453A1 Triazolo-pyridazine protein kinase modulators
1 ... 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 ... 111